ampelopsin has been researched along with Diabetes Mellitus in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cao, Z; Wang, Z; Yang, Z; Yue, Z | 1 |
| Huang, S; Jin, R; Li, X; Tan, L; Tong, H; Zhang, X | 1 |
2 review(s) available for ampelopsin and Diabetes Mellitus
| Article | Year |
|---|---|
Research progress of dihydromyricetin in the treatment of diabetes mellitus.
Topics: Diabetes Mellitus; Flavonols; Humans; Hyperglycemia; Phosphatidylinositol 3-Kinases | 2023 |
Multitarget and promising role of dihydromyricetin in the treatment of metabolic diseases.
Topics: Animals; Atherosclerosis; Diabetes Mellitus; Flavonols; Gene Expression Regulation; Humans; Hypoglycemic Agents; Metabolic Diseases; Non-alcoholic Fatty Liver Disease; Osteoporosis; Signal Transduction | 2020 |